Marco Londei
Keine laufenden Positionen mehr
Profil
Marco Londei worked as the Head-Therapeutic Area Immunosciences at Bristol Myers Squibb Co. from 2012 to 2014.
Prior to that, he was the Global Head-Autoimmunity Translational Medicine at Novartis Corp.
from 2005 to 2008.
From 2014 to 2020, he served as the Chief Medical Officer at AnaptysBio, Inc. He was also a Professor at Imperial College London from 1999 to 2013 and a Professor & Head-Gastroenterology Unit at University College London from 2003 to 2007.
Additionally, he worked as a Translational Science Officer at Novartis Institute for Functional Genomics, Inc. from 2005 to 2012.
Dr. Londei earned a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Ehemalige bekannte Positionen von Marco Londei
| Unternehmen | Position | Ende |
|---|---|---|
| ANAPTYSBIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.03.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.09.2014 |
| Imperial College London | Corporate Officer/Principal | 01.07.2013 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.10.2012 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.08.2008 |
Ausbildung von Marco Londei
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
